155 related articles for article (PubMed ID: 8422284)
1. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
Verweij J; Krzemieniecki K; Kok T; Poveda A; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1993; 29A(2):208-9. PubMed ID: 8422284
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.
Planting AS; Stoter G; Verweij J
Eur J Cancer; 1993; 29A(4):518-9. PubMed ID: 8435202
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study.
Verweij J; Judson I; Steward W; Coleman R; Woll P; van Pottelsberghe C; van Glabbeke M; Mouridsen H
Eur J Cancer; 1994; 30A(6):842-3. PubMed ID: 7917546
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.
Buys SS; Metch B; Balcerzak SP; Neefe JR; Stuckey WJ
Cancer Invest; 1994; 12(4):399-402. PubMed ID: 8032960
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
Bailey HH; Mahoney MR; Ettinger DS; Maples WJ; Fracasso PM; Traynor AM; Erlichman C; Okuno SH
Cancer; 2006 Nov; 107(10):2462-7. PubMed ID: 17058289
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group.
Mouridsen HT; Bastholt L; Somers R; Santoro A; Bramwell V; Mulder JH; van Oosterom AT; Buesa J; Pinedo HM; Thomas D
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1477-83. PubMed ID: 3479329
[TBL] [Abstract][Full Text] [Related]
7. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase II trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.
Buesa JM; Mouridsen HT; Santoro A; Somers R; Bramwell V; van Oosterom AT; Wagener T; Vendrik C; Thomas D
Cancer Treat Rep; 1984 Apr; 68(4):683-4. PubMed ID: 6713423
[No Abstract] [Full Text] [Related]
9. High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
Buesa JM; Mouridsen HT; van Oosterom AT; Verweij J; Wagener T; Steward W; Poveda A; Vestlev PM; Thomas D; Sylvester R
Ann Oncol; 1991 Apr; 2(4):307-9. PubMed ID: 1868027
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Steward WP; Mouridsen HT; Kerbrat P; Somers R; Verweij J; Van Oosterom AT; Blackledge G; Havsteen H; Thomas D; Sylvester R
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1251-3. PubMed ID: 2767113
[No Abstract] [Full Text] [Related]
11. Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.
Kerbrat P; Somers R; Verweij J; Crowther D; Tursz T; Santoro A; Steward WP; Lentz MA; van Glabbeke M; Mouridsen HT
Eur J Cancer; 1992; 29A(1):143-4. PubMed ID: 1445732
[No Abstract] [Full Text] [Related]
12. VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.
Dombernowsky P; Buesa J; Pinedo HM; Santoro A; Mouridsen H; Somers R; Bramwell V; Onsrud M; Rouesse J; Thomas D
Eur J Cancer Clin Oncol; 1987 May; 23(5):579-80. PubMed ID: 3653181
[No Abstract] [Full Text] [Related]
13. Mitomycin C (MCC) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
van Oosterom AT; Santoro A; Bramwell V; Davy M; Mouridsen HT; Thomas D; Sylvester R
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):459-61. PubMed ID: 3924625
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Wagener DJ; Somers R; Santoro A; Verweij J; Woll PJ; Blackledge G; Schütte HJ; Lentz MA; van Glabbeke M
Eur J Cancer; 1991; 27(12):1604-5. PubMed ID: 1782068
[TBL] [Abstract][Full Text] [Related]
15. Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group.
Gwyther SJ; Nielsen OS; Judson IR; van Glabbeke M; Verweij J
Anticancer Drugs; 2000 Jul; 11(6):433-7. PubMed ID: 11001383
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas.
Borden EC; Amato DA; Edmonson JH; Ritch PS; Shiraki M
Cancer; 1990 Sep; 66(5):862-7. PubMed ID: 2201431
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma.
Brenner J; Magill GB; Sordillo PP; Cheng EW; Yagoda A
Cancer; 1982 Nov; 50(10):2031-3. PubMed ID: 6889911
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial.
Knowling M; Blackstein M; Tozer R; Bramwell V; Dancey J; Dore N; Matthews S; Eisenhauer E
Invest New Drugs; 2006 Sep; 24(5):435-9. PubMed ID: 16528479
[TBL] [Abstract][Full Text] [Related]
19. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
Verweij J; Lee SM; Ruka W; Buesa J; Coleman R; van Hoessel R; Seynaeve C; di Paola ED; van Glabbeke M; Tonelli D; Judson IR
J Clin Oncol; 2000 May; 18(10):2081-6. PubMed ID: 10811673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
